Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05LOB
|
|||
| Former ID |
DIB014239
|
|||
| Drug Name |
FP-1201
|
|||
| Synonyms |
Traumagen; Traumakine; MR-11-A-8; CD73 agonist (intravenous, ALI/ARDS/neonatal RDS/ischemia), Faron Pharmaceuticals/MaruishiPharmaceutical; Interferon beta-1a (intravenous, ALI/ARDS/neonatal RDS/ischemia), Faron Pharmaceuticals/Maruishi Pharmaceutical
Click to Show/Hide
|
|||
| Indication | Acute lung injury [ICD-11: NB32.3; ICD-10: S27.3; ICD-9: 518] | Phase 3 | [1] | |
| Company |
Faron Pharmaceuticals Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Faron Pharmaceuticals. | |||
| REF 2 | The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.Lancet Respir Med. 2014 Feb;2(2):98-107. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.